Information for:


Click here if you are a healthcare professional and would like more information on Pradaxa® (dabigatran etexilate)

Information intended for:


Click here for more information on Pradaxa®

PC-GB -101423 V1 January 2021

Information for UK and Irish patients who have been prescribed Pradaxa (dabigatran etexilate), their carers and the public

Pradaxa® (dabigatran etexilate) is a type of medicine called an anticoagulant and is designed to reduce the chance of blood clots forming. It does this by working to stop blood cells from clumping together. It is used in people with a number of different conditions in order to help to reduce serious illnesses, such as strokes or deep vein thrombosis, from occuring.

As this medicine affects blood clotting, most side effects are related to signs such as bruising or bleeding. If you experience any bleeding event that does not stop by itself or if you experience signs of excessive bleeding (exceptional weakness, tiredness, paleness, dizziness, headache or unexplained swelling) consult your doctor immediately. 

To find out more about Pradaxa to prevent or treat blood clots for certain conditions, follow the links below.

Stopping the effects of Pradaxa in an emergency

If you have been prescribed Pradaxa and you need an emergency surgery/urgent procedure, or you experience life-threatening or uncontrolled bleeding, your doctor may decide that rapid inactivation of the effect of Pradaxa is required. This is done by using another medicine called Praxbind (idarucizumab), which rapidly traps Pradaxa in order to inactivate its effect.

Praxbind can only be used for patients taking Pradaxa, so you should ensure that you inform your healthcare professionals that you are taking Pradaxa and ensure that you carry your Patient Alert Card at all times.


Please note that this website is designed for information and reference purposes only. It is not intended to replace the advice of a healthcare professional. You should consult your doctor or another suitably trained healthcare professional if you have any questions or concerns regarding your health conditions or medications, and report any side effects to them immediately.

NP-GB-100695 V1 | August 2020


You are about to leave the Boehringer Ingelheim site for a site not created, managed or maintained by Boehringer Ingelheim.

Boehringer Ingelheim hopes that this link will be of interest and use to visitors, but it accepts no liability in relation to the website or its contents and gives no warranty as to the accuracy or completeness of information, data or reports on the website, to the fullest extent that any such liability may be lawfully excluded. Nor does Boehringer Ingelheim necessarily endorse or support any content on the third party website or any further links from their website.